All News

March 5, 2026

Multidisciplinary clinic improves care for cleft lip/palate patients

A patient care coordinator now works to ensure that families receive a comprehensive care plan rather than needing to coordinate multiple disparate parts of their child’s treatment on their own.

March 5, 2026

Thyroid cancer ‘atlas’ points to cell types that contribute to disease progression

A multi-institutional study led by Vanderbilt Health investigators provides a spatial understanding of thyroid cancer evolution and identifies cell types that may predict aggressive disease in both children and adults.

March 5, 2026

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.

March 3, 2026

Vanderbilt Health and Bertis establish collaboration for cancer drug discovery

The collaboration will integrate Vanderbilt Health’s Molecular AI Initiative capabilities with Bertis’ deep proteomics and AI-enabled technologies to identify novel therapeutic targets and predictive biomarkers.

March 3, 2026

Study led by Monroe Carell Jr. Children’s Hospital at Vanderbilt looks at international cohort with rare cancer

Novel research is paving way for less invasive therapies for gliomas in pediatric patients.

March 3, 2026

Vanderbilt Tullahoma-Harton Hospital receives national designation for treating patients with chest pain

Hospitals that earn accreditation have proven exceptional competency in treating patients with heart attack symptoms. The new designation will last until Jan. 31, 2029.